Category: Quadax Blog
Mitigating the Financial Consequences of COVID-19
Navigating Reimbursement for Liquid Biopsy Cancer Testing
The Right Automation is More Important Than Ever
COVID-19: Insurers Exempt from Covering Workplace Testing
Must Cover “Medically Appropriate” Tests Only
The rapid rollout in March of the federal FFCRA (Families First Coronavirus Response Act) and CARES (Coronavirus Aid, Relief and Economic Security Act) Acts – and specifically section 6001 of the FFCRA, which defines requirements for insurers – has left providers, labs and insurers uncertain, at times, of their respective responsibilities for COVID-19 testing.
Avoid the Top 3 RCM Pitfalls with Automation
Using different systems for RCM may be holding back productivity and hitting your bottom line.
The 2019 CAQH Index reported that the healthcare industry is spending approximately $350 billion annually for administration due to its complexity, and that about one-third of that amount could be saved by automating administrative transactions. For many, the mind-boggling $13.3 billion in available cost savings cited in the study begs this question: If healthcare revenue cycle management (RCM) technology has been evolving for over two decades, and the point of most technology is to help processes run more efficiently, what is causing administration costs to be sky-high with such an enormous opportunity for savings?
12 Tips to Recover Patient Volume and Finances After COVID-19
Life After COVID: The Impact on Hospitals & Physician Practices
The Road to Recovery – Resuming Elective Surgeries
Telemedicine: Adoption Rates, Barriers to Adoption, and The Future
Telemedicine has been a hot topic in the healthcare industry for a decade now. Every year, analysts have predicted telemedicine would become more of a priority for healthcare providers. However, adoption rates remained low until the outbreak of COVID-19 forced healthcare providers to embrace telemedicine to recoup drastically declining revenue.